Taipei Exchange - Delayed Quote TWD

Anti-Microbial Savior BioteQ Co., Ltd (6864.TWO)

88.30
-0.60
(-0.67%)
At close: May 29 at 2:59:55 PM GMT+8
Loading Chart for 6864.TWO
  • Previous Close 88.90
  • Open 88.90
  • Bid 87.80 x --
  • Ask 88.30 x --
  • Day's Range 87.80 - 89.20
  • 52 Week Range 24.35 - 125.50
  • Volume 69,321
  • Avg. Volume 133,745
  • Market Cap (intraday) 2.856B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -2.46
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Anti-Microbial Savior BioteQ Co., Ltd. focuses on the research and development of pharmaceutical products in Taiwan. The company was founded in 2018 and is based in Kaohsiung, Taiwan.

www.ams-bioteq.com

--

Full Time Employees

--

Fiscal Year Ends

Recent News: 6864.TWO

View More

Performance Overview: 6864.TWO

Trailing total returns as of 5/29/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

6864.TWO
45.23%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
7.33%

1-Year Return

6864.TWO
237.67%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
1.46%

3-Year Return

6864.TWO
198.13%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
31.24%

5-Year Return

6864.TWO
73.33%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
95.09%

Compare To: 6864.TWO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 6864.TWO

View More

Valuation Measures

Annual
As of 5/29/2025
  • Market Cap

    2.86B

  • Enterprise Value

    2.66B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.58k

  • Price/Book (mrq)

    12.04

  • Enterprise Value/Revenue

    4.35k

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    -2.46

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 6864.TWO

View More

Company Insights: 6864.TWO

Research Reports: 6864.TWO

View More

People Also Watch